Sartorius has announced the completed acquisition of some life science businesses of Danaher for a total of $825 million.
List view / Grid view
Filter the results
Innovations in single-use process automation are driving single-use adoption into commercial biologics facilities. Here, Sartorius Stedim Biotech (SSB) shares its latest service offering.
Get QC Results for Advanced Therapy Medicinal Products (ATMPs) Before Treatment.
Whitepaper: Impact of the Claristep® Filtration System on recovery and adsorption of various therapeutic proteins at low sample volumes
Comparison of the Sartorius Claristep Filtration System with standard sample preparation using syringe filters.
This whitepaper demonstrates the High Performance Liquid Chromatography (HPLC) separation and analysis technique and highlights the importance of using water of sufficient purity as an eluent and how the arium® pro VF system can facilitate this.
Leading international partner to the biopharmaceutical industry Sartorius Stedim Biotech (SSB) has today announced that the new SIMCA® 16 software for multivariate data analytics is available from its subsidiary Sartorius Stedim Data Analytics.
Application note: Benchmarking the Microsart® AMP Mycoplasma kit against products from two other suppliers
This application note compares Sartorius' Microsart AMP Mycoplasma kit with two other mycoplasma detection kits that are also based on DNA isolation with subsequent real-time PCR analysis.
Sartorius' Cubis® II balance series offers customisable modularity to ensure compliance with FDA directive 21 CFR Part II and EU Annex 11. This whitepaper outlines details of the technical solutions that will enable companies to achieve full compliance.
Fully customisable enabling thousands of configurations optimised for the user’s workflow and easy, seamless integration with existing lab software and LIMS...
Sartorius Stedim Biotech (SSB) BioOutsource today announced its expert technical staff will be speaking at and/or attending BIOLATAM, Biosimilars LATAM and Biosimilars and Biobetters conferences from November 16-19. This will provide developers of biosimilars with an excellent opportunity to discuss the optimum assay design for rapid and accurate biosimilar characterisation…
Sartorius Stedim Biotech, a leading international supplier for the biopharmaceutical industries and GE Healthcare’s Life Sciences business, a provider of start-to-finish enterprise solutions, technologies and services for biopharmaceutical manufacturing, today announced they have entered into a worldwide OEM supply agreement for Sartorius Stedim Biotech’s innovative membrane adsorber purification technology, Sartobind™.
Sartorius Stedim Biotech (SSB), a leading international supplier for the pharma and biotech industries, acquired Cellca GmbH based in Laupheim, Germany. Founded in 2005, the company with around 30 employees generated sales revenue of approximately 6 million euros in 2014.
Sartorius Stedim Biotech (SSB), a leading international supplier for the biopharmaceutical industries, today acquired the Scottish company BioOutsource Ltd.